Since this year, artificial intelligence, robotics, and innovative drugs known as the “three new and new” have developed rapidly, and are expected to form a new pillar industry. According to the data, the weekly usage volume of China's big model increased for 8 consecutive weeks, ranking first in the world for 12 consecutive weeks; in the first half of the year, China's robot exports were 6.29 billion yuan, exported to 141 countries and regions, and the export value of surgical robots increased 3.3 times; in the first half of the year, China's innovative drug authorized transactions were about 110 billion US dollars, and Chinese pharmaceutical companies occupied 8 seats in the top ten global pharmaceutical transactions.

Since this year, artificial intelligence, robotics, and innovative drugs known as the “three new and new” have developed rapidly, and are expected to form a new pillar industry. According to the data, the weekly usage volume of China's big model increased for 8 consecutive weeks, ranking first in the world for 12 consecutive weeks; in the first half of the year, China's robot exports were 6.29 billion yuan, exported to 141 countries and regions, and the export value of surgical robots increased 3.3 times; in the first half of the year, China's innovative drug authorized transactions were about 110 billion US dollars, and Chinese pharmaceutical companies occupied 8 seats in the top ten global pharmaceutical transactions.